Jeffrey Way

Company: Wyss Institute at Harvard University

Job title: President

Seminars:

Innovations in Bi-Specific & Multi-Specific Antibodies: Navigating Challenges & Enhancing Therapeutic Efficacy 2:00 pm

Exploring the rationale behind moving beyond traditional monospecific antibodies Addressing the complexities involved in developing Bi-Specific Antibodies Discussing strategies and innovations to overcome challenges in the development processRead more

day: Day One

Panel Discussion: Machine Learning in Antibody Engineering: Current Challenges & Future Prospects 4:30 pm

Exploring the potential of machine learning in optimizing the Antibody discovery and engineering process Discussing the challenges, particularly in acquiring and formatting the necessary data for effective machine learning Addressing the challenges and opportunities each company size faces in leveraging tools like machine learningRead more

day: Day One

Targeting Erythropoietin Activity to a Subset of Receptor-Bearing Cells Via in Cis Binding to a Secondary Receptor 11:30 am

Side effects can be undetectable at the right dose with a correctly targeted fusion protein Quantitative design specifications can guide molecular design • Cell-targeted drugs can be used to dissect molecular mechanisms A challenge for AI: A four-dimensional picture of the cell surface for fusion protein designRead more

day: Day Two

Panel Discussion: Exploring Early Developability in Antibody & Fusion Protein Engineering 4:00 pm

Incorporating early developability assessments in the drug discovery process Overcoming challenges related to chemical and physical properties Exploring technology advancements in early developability assessments Discussing the evolving landscape of early developability assessmentsRead more

day: Day Two